The weekly litigation news digest is live. Subscribe now

Immunohistochemical Assay For Detecting Expression Of Programmed Death Ligand 1 (Pd-L1) In Tumor Tissue - EP2981821

The patent EP2981821 was granted to Merck Sharp & Dohme on Nov 3, 2021. The application was originally filed on Mar 31, 2014 under application number EP14778739A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2981821

MERCK SHARP & DOHME
Application Number
EP14778739A
Filing Date
Mar 31, 2014
Status
Patent Maintained As Amended
Oct 1, 2021
Publication Date
Nov 3, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FORSYTHESep 19, 2019J A KEMPADMISSIBLE

Patent Citations (25) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP19890303964
DESCRIPTIONEP0216846
DESCRIPTIONEP0256055
DESCRIPTIONEP0323997
DESCRIPTIONUS4275149
DESCRIPTIONUS4318980
DESCRIPTIONUS4399216
DESCRIPTIONUS4737456
DESCRIPTIONUS4740461
DESCRIPTIONUS4816567
DESCRIPTIONUS4912040
DESCRIPTIONUS4959455
DESCRIPTIONUS6331415
DESCRIPTIONUS7521051
DESCRIPTIONUS8008449
DESCRIPTIONUS8354509
DESCRIPTIONUS8383796
INTERNATIONAL-SEARCH-REPORTUS2010266617
INTERNATIONAL-SEARCH-REPORTUS2012251537
INTERNATIONAL-SEARCH-REPORTUS2013064882
INTERNATIONAL-SEARCH-REPORTWO2010132958
OPPOSITIONWO2007082154
OPPOSITIONWO2008156712
OPPOSITIONWO2013173223
SEARCHWO2008156712

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents